Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...
MedPage Today on MSN
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to ...
T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to ...
News Medical on MSN
Leveraging the power of T cells for more effective and durable cancer immunotherapies
T cells play central roles in the adaptive immune response against cancer. Their functional inactivation is a primary driver of tumor progression, making the reactivation of T cell function a main ...
Moderna’s mRNA-4359, when used with Keytruda, achieves a 24% overall objective response rate in patients with melanoma, with ...
mRNA-4359 combined with pembrolizumab achieved a 24% ORR and 67% efficacy in PD-L1 positive melanoma patients. The study ...
Scott Tagawa, MD, highlights the PSMAddition trial's promising results, showcasing Lutetium-177 PSMA-617's significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback